Cannabis in Canada

Canada made history on October 17, 2018, becoming the second country in the world (after Uruguay) and the first G7 nation to legalize recreational cannabis nationwide. The Cannabis Act (Bill C-45) established a comprehensive federal regulatory framework governing the production, distribution, sale, and possession of cannabis across all provinces and territories.

The Canadian cannabis market is regulated by Health Canada at the federal level, with provinces and territories controlling distribution and retail sales. This has created a patchwork of retail models — from government-run stores in Quebec and Nova Scotia to private retail in Alberta and Ontario. Licensed producers (LPs) must obtain federal cultivation and processing licenses, and all products must meet strict quality and labeling standards.

Canada's legal cannabis market generated approximately $4.7 billion in annual sales by 2025, though the industry has faced significant challenges including oversupply, price compression, and widespread financial losses among publicly traded LPs. The illicit market has proven more persistent than initially projected, with estimates suggesting it still accounts for 30-40% of total cannabis consumption. Major Canadian cannabis companies including Tilray, Canopy Growth, Aurora Cannabis, and SNDL are publicly traded on major North American exchanges and represent some of the most widely followed cannabis stocks globally.

Despite these headwinds, Canada's cannabis market is maturing. Consolidation has reduced the number of active LPs, margins have improved for efficient operators, and the product mix has shifted toward higher-margin categories like edibles, extracts, and beverages. Canada also serves as a base for international expansion, with several Canadian LPs operating in European and other global markets.